Trial intelligence / Profile preview

Indomethacin and Etoricoxib in Axial Spondyloarthritis

NCT03582332Phase 4Completed

Sponsor
Bangabandhu Sheikh Mujib Medical University
Start
Jan 2016
Primary completion
Jun 2016
Modality
Small Molecules
01

Overview

A Phase 4 trial of indomethacin, etoricoxib in axial spondyloarthritis (axSpA), sponsored by Bangabandhu Sheikh Mujib Medical University. Started Jan 2016; status: completed.

02

Drugs

indomethacinetoricoxib
03

Conditions

axial spondyloarthritis (axSpA)

Beyond the preview

Go deeper on NCT03582332.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03582332.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call